uce
ProgressImage ProgressImage
Alpa Laboratories Ltd
Pharmaceuticals - Indian - Formulations
BSE Code 532878 border-img ISIN Demat INE385I01010 border-img Book Value 72.87 border-img NSE Symbol ALPA border-img Div & Yield % 0 border-img Market Cap ( Cr.) 203.48 border-img P/E 11.38 border-img EPS 8.5 border-img Face Value 10
Quarters
ParticularsDec 2023
()
Sep 2023
()
Jun 2023
()
Gross Sales27.3132.3925.43
Other Operating Income0.000.000.00
Other Income 3.552.954.47
Total Income30.8635.3529.90
Total Expenditure 24.8529.0826.58
PBIDT6.016.273.32
Interest 0.030.040.02
PBDT5.986.233.30
Depreciation0.660.490.28
Tax0.000.000.00
Fringe Benefit Tax0.000.000.00
Deferred Tax0.790.000.00
Reported Profit After Tax4.535.743.03
Extra-ordinary Items 0.020.000.03
Adjusted Profit After Extra-ordinary item4.515.743.00
    
EPS (Unit Curr.)2.152.751.44
EPS (Adj) (Unit Curr.)2.152.751.44
Calculated EPS (Unit Curr.)2.152.731.44
Calculated EPS (Adj) (Unit Curr.)2.152.731.44
Calculated EPS (Ann.) (Unit Curr.)8.6110.915.75
Calculated EPS (Adj) (Ann.) (Unit Curr.)8.6110.915.75
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity21.0421.0421.04
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)22.0119.3613.06
PBDTM(%)21.9019.2312.98
PATM(%)16.5917.7211.92
x
x
×
Let's Chat
close
refresh